SmPC - Miglustat 100mg Hard Capsules: Change history
View Summary of Product Characteristics (SmPC - Miglustat 100mg Hard Capsules)
Last updated on this site: 15 Aug 2024
To update section 4.4 of the SmPC in line with reference product, Zavesca 100mg hard capsules (PLGB 00242/0674; MAH Janssen-Cilag Limited). Consequently, the PIL has been updated.
View Summary of Product Characteristics (SmPC - Miglustat 100mg Hard Capsules)
Last updated on this site: 15 Aug 2024
To update section 4.4 of the SmPC in line with reference product, Zavesca 100mg hard capsules (PLGB 00242/0674; MAH Janssen-Cilag Limited). Consequently, the PIL has been updated.
-
Changes: (Updated: 15 Aug 2024)
To update section 4.4 of the SmPC in line with reference product, Zavesca 100mg hard capsules (PLGB 00242/0674; MAH Janssen-Cilag Limited). Consequently, the PIL has been updated.
-
Changes: (Updated: 06 Dec 2022)
To register an update to sections – 4.4, 4.6, 4.8, 5.3 and 10.
-
Changes: (Updated: 21 Sep 2022)
Initial upload